|
Variable |
Total Study Population |
Patients
free from ATAs |
Patients with ATA recurrence |
Statistical Significance |
|
Number of Patients
(% of Total Population)
|
174
|
76% (114/150)
|
24%
(36/150)
|
|
|
Mean Age (\(\pm\)SD)
|
60.1 years
(\(\pm\)10.1)
(n = 174)
|
59.7 years
(\(\pm\)9.8)
(n = 114)
|
61.9 years
(\(\pm\)11.0)
(n = 36)
|
p = 0.2626*
|
|
% Male Sex
|
72%
(126/174)
|
72%
(82/114)
|
69%
(25/36)
|
p = 0.7737†
|
|
% White Race |
100% (174/174) |
|
|
|
|
% Mean BMI (\(\pm\)SD)
|
32.0 (\(\pm\)6.8)
(n = 174)
|
31.9 (\(\pm\)6.8)
(n=114)
|
32.1 (\(\pm\)8.0)
(n=36)
|
p = 0.8706*
|
|
% with BMI ≥30
|
59%
(102/174)
|
59%
(67/114)
|
56%
(20/36)
|
p = 0.7332†
|
|
% with HLD
|
55%
(95/174)
|
55%
(63/114)
|
61%
(22/36)
|
p = 0.5370†
|
|
% with PVD
|
5%
(9/174)
|
4%
(5/114)
|
11%
(4/36)
|
p = 0.2191‡
|
|
% with prior CVA
|
14% (23/161)
|
14% (17/125)
|
17%
(3/36)
|
p = 0.6431†
|
|
% with CHA2DS2-VASc ≥ 2
|
77%
(134/174)
|
76%
(87/114)
|
75%
(27/36)
|
p = 0.8720†
|
|
% with HTN
|
67%
(116/174)
|
65%
(74/114)
|
69%
(25/36)
|
p = 0.6168†
|
|
% Ever Smokers
|
36%
(62/174)
|
33%
(38/114)
|
44%
(16/36)
|
p = 0.2260†
|
|
% with Chronic Lung Disease
|
10%
(17/174)
|
9%
(10/114)
|
14%
(5/36)
|
p = 0.3556‡
|
|
% with DM
|
14%
(25/174)
|
14%
(16/114)
|
14%
(5/36)
|
p = 0.9824†
|
|
% with Renal Failure
|
0%
(0/174)
|
|
|
|